B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

The American Journal of Surgical Pathology
Matija SnuderlAliyah R Sohani

Abstract

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit" lymphomas (DHL), are rare neoplasms characterized by highly aggressive clinical behavior, complex karyotypes, and a spectrum of pathologic features overlapping with Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and B-lymphoblastic lymphoma/leukemia (B-LBL). The clinical and pathologic spectrum of this rare entity, including comparison to other high-grade B-cell neoplasms, has not been well defined. We conducted a retrospective analysis of clinical and pathologic features of 20 cases of DHL seen at our institution during a 5-year period. In addition, we carried out case-control comparisons of DHL with BL and International Prognostic Index (IPI)-matched DLBCL. The 11 men and 9 women had a median age of 63.5 years (range 32 to 91). Six patients had a history of grade 1 to 2 follicular lymphoma; review of the prior biopsy specimens in 2 of 5 cases revealed blastoid morphology. Eighteen patients had Ann Arbor stage 3 or 4 disease and all had elevated serum lactate dehydrogenase (LDH) levels at presentation. Extranodal disease was present in 17/20 (85%), bone marrow involvement in 10/17 (59%) and central nervous system (CNS) di...Continue Reading

References

Nov 5, 1987·The New England Journal of Medicine·L M WeissM L Cleary
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·L PegoraroC M Croce
Jun 1, 1994·Cancer Genetics and Cytogenetics·R B van OoteghemA Hagemeijer
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U VitoloL Resegotti
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MacphersonR D Gascoyne
Apr 11, 2000·The American Journal of Surgical Pathology·Y NatkunamP J Cornbleet
Nov 9, 2000·Leukemia·A StamatoullasH Tilly
Dec 20, 2000·Cancer Genetics and Cytogenetics·K F Wong, J K Chan
Apr 24, 2003·Archives of Pathology & Laboratory Medicine·Cherie H DunphyGeorgette A Dent
Jul 9, 2004·International Journal of Hematology·Keiki KawakamiIkuo Miura
Mar 25, 2005·Journal of Gambling Studies·Robert Ladouceur, Howard J Shaffer
Apr 27, 2005·Genes, Chromosomes & Cancer·José Ignacio Martín-SuberoReiner Siebert
Jun 11, 2005·Human Pathology·Sanjay MukhopadhyayJagmohan S Sidhu
Oct 15, 2005·The American Journal of Surgical Pathology·Sa A WangRobert P Hasserjian
Nov 1, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anuradha KanungoPei Lin
Jun 9, 2006·The New England Journal of Medicine·Michael HummelUNKNOWN Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe
Jun 9, 2006·The New England Journal of Medicine·Sandeep S DaveUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Jul 20, 2006·British Journal of Haematology·Sergio B CogliattiUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Nov 1, 2006·Cancer Genetics and Cytogenetics·Pina D'AchilleLynda J Campbell
Apr 23, 2008·Current Protocols in Human Genetics·Stanislawa Weremowicz, Deborah E Schofield
Aug 14, 2008·Haematologica·Itziar SalaverriaUNKNOWN Leukemia and Lymphoma Molecular Profiling Project (LLMPP)
Aug 30, 2008·The American Journal of Surgical Pathology·Aliyah RahemtullahJudith A Ferry
Jan 6, 2009·British Journal of Haematology·Noraidah MasirAbigail M Lee
Mar 6, 2009·Leukemia·K Stegmaier

❮ Previous
Next ❯

Citations

Feb 3, 2011·Annals of Hematology·Gayatri VaidyanathanFrancisco J Hernandez-Ilizaliturri
Dec 31, 2010·Current Hematologic Malignancy Reports·Deborah A ThomasHagop Kantarjian
Jul 31, 2013·Current Hematologic Malignancy Reports·Pei Lin, L Jeffrey Medeiros
Oct 23, 2012·International Journal of Hematology·Mark RoschewskiWyndham H Wilson
Aug 4, 2012·Bone Marrow Transplantation·S O AhmedM Aljurf
Oct 18, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shaoying LiL Jeffrey Medeiros
Sep 14, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anne Pham-LedardJean-Philippe Merlio
Nov 13, 2013·Nature Reviews. Clinical Oncology·Mark RoschewskiWyndham H Wilson
Nov 15, 2013·The New England Journal of Medicine·Jeffrey A BarnesAliyah R Sohani
Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SoldiniM Tinguely
Apr 17, 2012·Current Opinion in Hematology·R Coleman Lindsley, Ann S LaCasce
May 6, 2010·The American Journal of Surgical Pathology·Marianna B RuzinovaScott J Rodig
Oct 22, 2010·The American Journal of Surgical Pathology·Alexandra ValeraElías Campo
Dec 14, 2011·Hematology·Elaine S Jaffe, Stefania Pittaluga
Nov 2, 2011·Internal Medicine·Tomohiro Yamazaki, Hitoshi Ohno
Apr 16, 2011·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Xiayuan LiangEdythe A Albano
May 30, 2013·Haematologica·Alexandra ValeraUNKNOWN Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB)
Jun 2, 2011·Journal of Clinical and Experimental Hematopathology : JCEH·Naoto Tomita
Sep 3, 2013·Journal of Clinical and Experimental Hematopathology : JCEH·Rie TabataMasaru Kojima
Aug 2, 2012·Archives of Pathology & Laboratory Medicine·Lauren B Smith, Scott R Owens
May 3, 2014·International Journal of Oncology·Kristy LeeMargaret E Tome
Nov 16, 2013·Cell Biochemistry and Biophysics·Yuan-yuan SongOu Bai
Feb 23, 2013·ISRN Hematology·Ronit Vogt Sionov
Jan 17, 2014·Journal of the American Medical Informatics Association : JAMIA·Yuan LuoPeter Szolovits
Mar 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Vaidya, T E Witzig
Aug 21, 2013·Leukemia & Lymphoma·Barbara BernasconiMaria Grazia Tibiletti
Jan 26, 2016·Expert Review of Hematology·Muhammad O Jamil, Amitkumar Mehta
Mar 31, 2015·Medicina clínica·Juan-Manuel SanchoUNKNOWN Working Group on Diagnosis, Prevention and Treatment of CNS Infiltration in Patients with DLBCL

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.